Leading Pharmaceutical and MedTech Executives to Share Best Practices
in Global Pricing Innovation and Commercial Excellence to Maximize
Revenue
REDWOOD CITY, Calif.--(BUSINESS WIRE)--
Model
N, Inc. (NYSE:MODN), the leading provider of cloud-based revenue
management solutions to life sciences, technology and manufacturing
companies, today announced it will host the Commercial and Pricing
Innovation Forum on October 10-12, 2017, at the Palais Hansen Kempinski
in Vienna, Austria. The Forum is designed to drive innovation among
thought leaders from industry experts and pharmaceutical, medical device
and technology companies.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20170925006556/en/
Model N to Host Life Sciences Commercial and Pricing Innovation ForumOct 10-12, 2017. (Photo: Business Wire)
“The Life Sciences Commercial and Pricing Innovation Forum is designed
to enable global pricing leaders to share best practices and to drive
further innovation,” said Zack Rinat, founder, executive chairman & CEO
of Model N. “We are excited to host this Forum to paint the role of
Cloud technology in driving end-to-end pricing, tendering and market
access.”
The Forum will bring together over 100 pharmaceutical and medical
devices executives from around the globe to discuss emerging
commercial-wide trends, recurring challenges faced by the industry and
best practices in global pricing, tender and revenue management.
“Tender planning is top of mind for commercial and pricing teams in Life
Sciences,” said Roman Irsiegler, senior marketing manager biosimilars at
Pfizer. “I am delighted to join a panel on tender management during this
forum, where I will zoom in on Biosimilars and present the perspective
of a mature and sophisticated market where tender and contracts are
essential to success.”
The two-day conference includes exclusive business cases, workshops and
user discussion groups that will deliver actionable insights for
pharmaceutical and medical devices executives involved with global
pricing and commercial improvement programs.
Sessions include:
- Global Pricing Strategy Throughout the Product Life Cycle
- Innovative Contracting Models: pitfalls and critical success
factors in various markets
- Tender Management: the current state of Tendering in medical
devices and pharmaceuticals, use of public data, Tender Planning, etc.
- Market Access strategies in Emerging Markets: strategies for
sustainable market access
- Value-Based Health Care: enrich the understanding of
value-based healthcare, its definition, barriers and opportunities
- Sales Approach Transformation: from product to solution sales
For more information on the event agenda,
speakers and registration, please visit the Forum’s site at www.modeln.com/CPIF2017.
About Model N
Model N is the leader in Revenue Management solutions. Driving mission
critical business processes such as configure, price and quote (CPQ),
contract and rebate management, business intelligence, and regulatory
compliance, Model N solutions transform the revenue lifecycle from a
series of disjointed operations into a strategic end-to-end process.
With deep industry expertise, Model N supports the complex business
needs of the world’s leading brands in life sciences, technology and
manufacturing across more than 100 countries, including Johnson &
Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology
and ON Semiconductor. For more information, visit www.modeln.com.
Model N® is the registered trademark of Model N, Inc. Any other company
names mentioned are the property of their respective owners and are
mentioned for identification purposes only.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170925006556/en/
Model N, Inc.
Laure Gaboriaud
pr@modeln.com
Source: Model N, Inc.